Scholarlink

Background <p> Deaths in schizophrenia are multifactorial, yet postmortem data from Türkiye are limited. This study evaluated demographic, clinical, and postmortem characteristics of patients with schizophrenia, with particular focus on antipsychotic use, death circumstances, and organ pathology.</p> Method <p>A retrospective analysis was conducted on 107 autopsy cases from 2020 to 2024. Data on demographics, clinical history, toxicology, and macroscopic organ findings were collected and analyzed.</p> Results <p>Most patients were male (70.1%) with a mean age of 50 ± 13.8 years. Natural deaths accounted for 56.1%, predominantly cardiovascular, whereas non-natural deaths comprised 43.9%, mainly trauma and asphyxia. Antipsychotics were detected in 61.3% of cases, often in combination, and antidepressants in 21.7%. Combined antipsychotic use was associated with a lower likelihood of being found dead.</p> Conclusion <p>Deaths in schizophrenia are influenced by cardiovascular, traumatic, metabolic, and pharmacological factors. Postmortem evaluations indicate limited macroscopic effects of psychotropic medications. Mortality risk assessment should integrate clinical, pharmacological, and sociodemographic factors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The end of fragmented consciousness: deaths in schizophrenia—an autopsy-based study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月19日

查看全文
  • Filiz Ekim Çevi̇k,
  • Aytül Buğra,
  • Muhammed Oduncu,
  • Yasin Kavla,
  • Hüseyin Çağrı Şahi̇n,
  • Muhammed Fatih Yaman,
  • Furkan Doğan,
  • Hatice Büşra Arisin,
  • İbrahim Üzün,
  • Hızır Asliyüksek

摘要

Background

Deaths in schizophrenia are multifactorial, yet postmortem data from Türkiye are limited. This study evaluated demographic, clinical, and postmortem characteristics of patients with schizophrenia, with particular focus on antipsychotic use, death circumstances, and organ pathology.

Method

A retrospective analysis was conducted on 107 autopsy cases from 2020 to 2024. Data on demographics, clinical history, toxicology, and macroscopic organ findings were collected and analyzed.

Results

Most patients were male (70.1%) with a mean age of 50 ± 13.8 years. Natural deaths accounted for 56.1%, predominantly cardiovascular, whereas non-natural deaths comprised 43.9%, mainly trauma and asphyxia. Antipsychotics were detected in 61.3% of cases, often in combination, and antidepressants in 21.7%. Combined antipsychotic use was associated with a lower likelihood of being found dead.

Conclusion

Deaths in schizophrenia are influenced by cardiovascular, traumatic, metabolic, and pharmacological factors. Postmortem evaluations indicate limited macroscopic effects of psychotropic medications. Mortality risk assessment should integrate clinical, pharmacological, and sociodemographic factors.